Global Tuberculosis Vaccines Market
Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at an advanced stage the sputum will contain blood and other symptoms include lack of appetite, weight loss, fever, and night sweats. Due to the COVID-19 pandemic, the global Tuberculosis Vaccines market size is estimated to be worth US$ 74 million in 2022 and is forecast to a readjusted size of US$ 90 million by 2030 with a CAGR of 2.8% during the forecast period 2023-2030. Fully considering the economic change by this health crisis, the Europe Tuberculosis Vaccines market is estimated at US$ million in 2023, while the United States and China are forecast to reach US$ million and US$ million by 2030, respectively. The proportion of the United States is % in 2023, while Chinese percentage...